Vol­un­teers sought for vi­ta­min D trial

Central Leader - - NEWS -

More than 100 peo­ple with pso­ri­a­sis are be­ing sought for an Auck­land­based vi­ta­min D trial.

The trial is at Massey Univer­sity’s Vi­ta­min D Re­search Cen­tre and is be­ing led by PhD stu­dent Michelle In­gram.

Ms In­gram says the study is ex­am­in­ing the po­ten­tial of vi­ta­min D as an alternative low-cost treat­ment to the un­com­fort­able con­di­tion.

Pso­ri­a­sis is a chronic, non-con­ta­gious in­flam­ma­tory skin disease.

An es­ti­mated one in 50 adults in New Zealand live with it. Plaque­based pso­ri­a­sis is the most com­mon type, and while it can be man­aged, there is no known cure.

Ms In­gram says peo­ple with pso­ri­a­sis of­ten avoid com­mon ac­tiv­i­ties such as swim­ming or go­ing to the hair­dresser.

She says the con­di­tion can have a sig­nif­i­cant im­pact on the suf­ferer’s self-es­teem.

‘‘If we are able to prove that vi­ta­min D can help re­lieve the symp­toms of pso­ri­a­sis, that’s a big step to­wards help­ing peo­ple with pso­ri­a­sis lead a more nor­mal life.’’

Tra­di­tional treat­ments for pso­ri­a­sis in­clude top­i­cal lo­tions, creams, pills or in­jec­tions, and pho­tother­apy. They can be in­con­ve­nient, ex­pen­sive, and in­crease the risk of other health prob­lems, Ms In­gram says.

Re­searchers for the trial are seek­ing pso­ri­a­sis suf­fer­ers aged 18 or older, with pla­que­type pso­ri­a­sis in ‘‘ac­tive phase’’ and sta­ble for the past two months.

Vol­un­teers must meet cer­tain cri­te­ria and be able to at­tend five ap­point­ments at the Al­bany-based cen­tre for as­sess­ments and sam­ples in a one-year pe­riod.

Newspapers in English

Newspapers from New Zealand

© PressReader. All rights reserved.